Ledger.Open graph →
SEC Form D · filed November 14, 2024

Eterna Therapeutics Inc

Offering
$1.1M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Casey Johnson · Cambridge, MAExec · DirectorDorothy Clarke · Cambridge, MAExec · DirectorWilliam Wexler · Cambridge, MADirectorSandra Gurrola · Cambridge, MAExecSanjeev Luther · Cambridge, MAExec · DirectorJames Bristol · Cambridge, MADirectorPeter Cicala · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗